Patents by Inventor Hyung L. Kim

Hyung L. Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11926793
    Abstract: Systems and methods are provided for improving product yields and/or product quality during co-processing of fast pyrolysis oil in a fluid catalytic cracking (FCC) reaction environment. The systems and methods can allow for co-processing of an increased amount of fast pyrolysis oil while reducing or minimizing coke production for a feedstock including fast pyrolysis oil and a conventional FCC feed. The reducing or minimizing of coke production can be achieved in part by adding a low molecular weight, non-ionic surfactant to the mixture of fast pyrolysis oil and conventional FCC feed.
    Type: Grant
    Filed: September 13, 2022
    Date of Patent: March 12, 2024
    Assignee: EXXONMOBIL TECHNOLOGY AND ENGINEERING COMPANY
    Inventors: Xiaochun Xu, Hyung Rae Kim, Chengrong Wang, Colin L. Beswick
  • Patent number: 8236320
    Abstract: Provided are methods for stimulating an immune response to an antigen by administering a composition to an individual in an amount effective to stimulate an immune response to the antigen. The stimulated immune response to the antigen is greater than the immune response stimulated by the antigen in the absence of CA9 protein. The compositions provided contain a complex that includes an antigen and an isolated CA9 protein.
    Type: Grant
    Filed: November 3, 2008
    Date of Patent: August 7, 2012
    Assignee: Health Research Inc.
    Inventors: Hyung L. Kim, Yanping Wang, Xiang-Yang Wang, John R. Subjeck
  • Publication number: 20100196311
    Abstract: Provided are compositions and methods for enhancing immune responses to an antigen. The compositions contain an isolated population of CD8+T cells and an inhibitor of mammalian target of rapamycin (mTOR). The method for obtaining an enhanced immune response to an antigen in an individual entails administering to the individual the antigen and an inhibitor of mammalian target of rapamycin (mTOR). CD8+T cells may also be used for adoptive cell transfer (ACT) therapy.
    Type: Application
    Filed: January 14, 2010
    Publication date: August 5, 2010
    Inventors: Hyung L. Kim, Protul Shrikant, YanPing Wang, Qingsheng Li, Rajesh Rao
  • Publication number: 20090142365
    Abstract: Provided are methods for stimulating an immune response to an antigen by administering a composition to an individual in an amount effective to stimulate an immune response to the antigen. The stimulated immune response to the antigen is greater than the immune response stimulated by the antigen in the absence of CA9 protein. The compositions provided contain a complex that includes an antigen and an isolated CA9 protein.
    Type: Application
    Filed: November 3, 2008
    Publication date: June 4, 2009
    Inventors: Hyung L. Kim, Yanping Wang, Xiang-Yang Wang, John R. Subjeck